EVAX
NASDAQ
$3.75
Evaxion Biotech A/S (EVAX)
Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company is headquartered in Hoersholm, Denmark.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $11.25 (+200.00%)
Market Cap
$34M
Free Cash Flow Yield
-19.68%
Beta (5Y)
0.76
Price Chart
Valuation
Market Cap$34M
Forward P/E3.57
P/S4.54
P/B2.14
Profitability
Total Revenue (TTM)$7.55M
Gross Profit (TTM)$7.53M
EBITDA-$11M
Profit Margin-129.6%
Operating Margin-122%
EPS-$7.34
Financial Health
Free Cash Flow Yield-19.68%
Growth & Risk
FCF 5Y CAGR-14.02%
Beta (5Y)0.76
Sharpe Ratio0.89